content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001873935</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001817713</issuerCik>
        <issuerName>Janux Therapeutics, Inc.</issuerName>
        <secFileNumber>001-40475</secFileNumber>
        <issuerAddress>
          <com:street1>10955 VISTA SORRENTO PARKWAY</com:street1>
          <com:street2>SUITE 200</com:street2>
          <com:city>SAN DIEGO</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92130</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>(858) 751-4493</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Avalon BioVentures I, LP</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>10% Stockholder</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Cowen &amp; Company LLC</name>
          <address>
            <com:street1>599 Lexington Avenue</com:street1>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10022</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>30613</noOfUnitsSold>
        <aggregateMarketValue>1438811.00</aggregateMarketValue>
        <noOfUnitsOutstanding>52164498</noOfUnitsOutstanding>
        <approxSaleDate>09/12/2024</approxSaleDate>
        <securitiesExchangeName>Nasdaq</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>11/13/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Open Market</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Open Market</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>30613</amountOfSecuritiesAcquired>
        <paymentDate>09/12/2024</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Avalon BioVentures I, LP</name>
          <address>
            <com:street1>11099 N TORREY PINES ROAD</com:street1>
            <com:street2>SUITE 290</com:street2>
            <com:city>LA JOLLA</com:city>
            <com:stateOrCountry>CA</com:stateOrCountry>
            <com:zipCode>92037</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <saleDate>09/10/2024</saleDate>
        <amountOfSecuritiesSold>8842</amountOfSecuritiesSold>
        <grossProceeds>402487.00</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Avalon BioVentures I, LP</name>
          <address>
            <com:street1>11099 N TORREY PINES ROAD</com:street1>
            <com:street2>SUITE 290</com:street2>
            <com:city>LA JOLLA</com:city>
            <com:stateOrCountry>CA</com:stateOrCountry>
            <com:zipCode>92037</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <saleDate>09/06/2024</saleDate>
        <amountOfSecuritiesSold>20991</amountOfSecuritiesSold>
        <grossProceeds>881622.00</grossProceeds>
      </securitiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>09/12/2024</noticeDate>
        <signature>Jay Lichter</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4069}]
text: 144
  0001873935
  XXXXXXXX
  LIVE
  0001817713
  Janux Therapeutics, Inc.
  001-40475
  10955 VISTA SORRENTO PARKWAY
  SUITE 200
  SAN DIEGO
  CA
  92130
  (858) 751-4493
  Avalon BioVentures I, LP
  10% Stockholder
  Common
  Cowen & Company LLC
  599 Lexington Avenue
  New York
  NY
  10022
  30613
  1438811.00
  52164498
  09/12/2024
  Nasdaq
  Common
  11/13/2023
  Open Market
  Open Market
  N
  30613
  09/12/2024
  Cash
  N
  Avalon BioVentures I, LP
  11099 N TORREY PINES ROAD
  SUITE 290
  LA JOLLA
  CA
  92037
  Common
  09/10/2024
  8842
  402487.00
  Avalon BioVentures I, LP
  11099 N TORREY PINES ROAD
  SUITE 290
  LA JOLLA
  CA
  92037
  Common
  09/06/2024
  20991
  881622.00
  09/12/2024
  Jay Lichter